OBJECTIVES: We hypothesized that a greater 2-year decline in office-based functional performance measures would be associated with greater mobility loss and mortality in people with peripheral arterial disease (PAD). BACKGROUND: Associations of decline in functional performance with clinically important outcomes in patients with PAD are unknown. METHODS: A total of 440 men and women with PAD completed the 6-min walk test and measures of walking velocity at baseline and annually for 2 years. Participants were categorized into tertiles according to their functional decline between baseline and 2-year follow-up and were followed annually after the functional change assessment. Cox proportional hazard models were used to assess relations between the 2-year change in functional performance with later mortality and mobility loss, with adjustments for age, sex, race, ankle brachial index, comorbidities, and other confounders. RESULTS: A total of 102 participants (23.2%) died during a median follow-up of 44.5 months after functional change was assessed. Of 319 participants without baseline mobility disability, 60 (18.8%) developed mobility loss after functional change was assessed. Participants in the tertile with the greatest 6-min walk decline had the highest subsequent mobility loss (hazard ratio [HR]: 3.50; 95% confidence interval [CI]: 1.56 to 7.85; p = 0.002), all-cause mortality (HR: 2.16; 95% CI: 1.28 to 3.64; p = 0.004), and cardiovascular disease mortality (HR: 2.45; 95% CI: 1.08 to 5.54; p = 0.031), compared with those with the smallest 6-min walk decline. Greater declines in fastest-paced 4-m walking velocity were associated with higher mobility loss (p trend = 0.018), all-cause mortality (p trend = 0.01), and cardiovascular mortality (p trend = 0.004). CONCLUSIONS: Participants with PAD with declining functional performance are at increased risk for later mobility loss and mortality.
OBJECTIVES: We hypothesized that a greater 2-year decline in office-based functional performance measures would be associated with greater mobility loss and mortality in people with peripheral arterial disease (PAD). BACKGROUND: Associations of decline in functional performance with clinically important outcomes in patients with PAD are unknown. METHODS: A total of 440 men and women with PAD completed the 6-min walk test and measures of walking velocity at baseline and annually for 2 years. Participants were categorized into tertiles according to their functional decline between baseline and 2-year follow-up and were followed annually after the functional change assessment. Cox proportional hazard models were used to assess relations between the 2-year change in functional performance with later mortality and mobility loss, with adjustments for age, sex, race, ankle brachial index, comorbidities, and other confounders. RESULTS: A total of 102 participants (23.2%) died during a median follow-up of 44.5 months after functional change was assessed. Of 319 participants without baseline mobility disability, 60 (18.8%) developed mobility loss after functional change was assessed. Participants in the tertile with the greatest 6-min walk decline had the highest subsequent mobility loss (hazard ratio [HR]: 3.50; 95% confidence interval [CI]: 1.56 to 7.85; p = 0.002), all-cause mortality (HR: 2.16; 95% CI: 1.28 to 3.64; p = 0.004), and cardiovascular disease mortality (HR: 2.45; 95% CI: 1.08 to 5.54; p = 0.031), compared with those with the smallest 6-min walk decline. Greater declines in fastest-paced 4-m walking velocity were associated with higher mobility loss (p trend = 0.018), all-cause mortality (p trend = 0.01), and cardiovascular mortality (p trend = 0.004). CONCLUSIONS:Participants with PAD with declining functional performance are at increased risk for later mobility loss and mortality.
Authors: R Altman; E Asch; D Bloch; G Bole; D Borenstein; K Brandt; W Christy; T D Cooke; R Greenwald; M Hochberg Journal: Arthritis Rheum Date: 1986-08
Authors: Kushang V Patel; Antonia K Coppin; Todd M Manini; Fulvio Lauretani; Stefania Bandinelli; Luigi Ferrucci; Jack M Guralnik Journal: Am J Prev Med Date: 2006-08-02 Impact factor: 5.043
Authors: R Altman; G Alarcón; D Appelrouth; D Bloch; D Borenstein; K Brandt; C Brown; T D Cooke; W Daniel; D Feldman Journal: Arthritis Rheum Date: 1991-05
Authors: M M McDermott; P Greenland; K Liu; J M Guralnik; M H Criqui; N C Dolan; C Chan; L Celic; W H Pearce; J R Schneider; L Sharma; E Clark; D Gibson; G J Martin Journal: JAMA Date: 2001-10-03 Impact factor: 56.272
Authors: Ramin Shadman; Michael H Criqui; Warner P Bundens; Arnost Fronek; Julie O Denenberg; Anthony C Gamst; Mary M McDermott Journal: J Am Coll Cardiol Date: 2004-08-04 Impact factor: 24.094
Authors: Mary McGrae McDermott; Kiang Liu; Philip Greenland; Jack M Guralnik; Michael H Criqui; Cheeling Chan; William H Pearce; Joseph R Schneider; Luigi Ferrucci; Lillian Celic; Lloyd M Taylor; Ed Vonesh; Gary J Martin; Elizabeth Clark Journal: JAMA Date: 2004-07-28 Impact factor: 56.272
Authors: Mary McGrae McDermott; Philip Greenland; Kiang Liu; Jack M Guralnik; Lillian Celic; Michael H Criqui; Cheeling Chan; Gary J Martin; Joseph Schneider; William H Pearce; Lloyd M Taylor; Elizabeth Clark Journal: Ann Intern Med Date: 2002-06-18 Impact factor: 25.391
Authors: Kazuki Hotta; Wayne B Batchelor; James Graven; Vishal Dahya; Thomas E Noel; Akash Ghai; John N Katopodis; William C Dixon; Rebecca Andrews; Aimee Pragle; Jegghna Chheda; Lia Liberatore; Brad J Behnke; Judy Muller-Delp Journal: Cardiovasc Revasc Med Date: 2019-05-10
Authors: Mary M McDermott; Jack M Guralnik; Michael H Criqui; Kiang Liu; Melina R Kibbe; Luigi Ferrucci Journal: Circulation Date: 2014-07-01 Impact factor: 29.690
Authors: Mary M McDermott; Tamar S Polonsky; Melina R Kibbe; Lu Tian; Lihui Zhao; William H Pearce; Ying Gao; Jack M Guralnik Journal: J Vasc Surg Date: 2017-05-11 Impact factor: 4.268
Authors: Odessa Addison; Alice S Ryan; Steven J Prior; Leslie I Katzel; Rishi Kundi; Brajesh K Lal; Andrew W Gardner Journal: J Geriatr Phys Ther Date: 2017 Oct/Dec Impact factor: 3.381
Authors: Nicholas J Leeper; Jonathan Myers; Margaret Zhou; Kevin T Nead; Arshiya Syed; Yoko Kojima; Roxanne Diaz Caceres; John P Cooke Journal: J Vasc Surg Date: 2012-10-06 Impact factor: 4.268